002020.SZ · 京新药业
China A-shares · RS rating 14 · As of 2026-10-14
| Price | 11.53 CNY |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 65 / 25 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 5 / 10 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +15.3% |
| Distance from 52-week high | +46.7% |
| Market cap (USD) | $1.5B |